Keywords: Sclerotherapy; Intramuscular venous malformation; Vascular malformation; DIC; Disseminated Intravascular Coagulopaty; IVM; Intramuscular Venous Malformation; LIC; Localized Intravascular Coagulopathy; LMWH; Low Molecular Weight Heparin; STS; Sodium Tetrad
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: thrombosis; peripherally inserted central catheters; central venous line; infant leukemia; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; CAT; Catheter-associated thrombosis; CVL; Central venous line; L-ASP; L-asparaginase; LMWH; Low-mole
Keywords: VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: CDT; Catheter Directed Thrombolysis; CT; Computed tomography; CTA; CT angiography; DOAC; direct oral anticoagulant; DUS; Doppler ultrasound; DVT; deep vein thrombosis; ECMO; Extra Corporeal Membrane Oxygenation; ICH; intracranial hemorrhage; ICU; intensiv
Keywords: 2; Achilles tendon; DVT; economic analysis; heparin; LMWH; QALY; venous thrombosis;
Keywords: urinary bladder neoplasms; cystectomy; venous thromboembolism; heparin; low-molecular-weight; AUA; American Urological Association; CrCl; creatinine clearance; DVT; deep venous thrombosis; EAU; European Association of Urology; ERAS®; enhanced recovery af
Keywords: Amax; maximal thrombin concentration; APTT; activated partial thromboplastin time; AT; antithrombin III; CVerror; relative random error of measurement; CVii; inter-individual coefficient of variability; CVtotal; total coefficient of variation; ETP; endoge
Keywords: critically ill; heparin; heparin-induced thrombocytopenia; thrombocytopenia; thrombosis; APTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DOAC; direct oral anticoagulant; ECMO; extracorporeal membrane oxygenation;
Keywords: CO; carbon monoxide; CPC; cerebral performance category; DVT; deep vein thrombosis; HBOT; hyperbaric oxygen treatment; LMWH; low-molecular-weight heparin; NOAC; new oral anticoagulant; PTE; pulmonary thromboembolism; COHb; CO hemoglobin; Carbon monoxide p
Keywords: AIS; Abbreviated Injury Scale; DVT; deep venous thrombosis; ED; emergency department; HR; heart rate; IQR; interquartile range; ISS; Injury Severity Score; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; pRBC; packed RBC; SBP; systolic blood p
Keywords: Dalteparin; LMWH; Renal cell carcinoma; Sunitinib; VEGF;
Keywords: VTE; venous thromboembolism; ACCP; American College of Chest Physicians; NICE; National Institute for Health and Care Excellence; GLIA; Guideline Implementability Appraisal; ICU; intensive care unit; CCU; cardiac care unit; CVC; central venous catheter; R
Keywords: CS; chitosan; GAG; glycosaminoglycan; DDA; degree of deacetylation; ECM; extracellular matrix; FFSA; 5-formyl-2-furansulfonic acid; BZ1S; 2-formylbenzene sulfonic acid; BZ2S; 4-formyl-1,3-benzenedisulfonic acid; APTT; activated partial thromboplastin time
Keywords: BCA; bicinchoninic acid; BRO; bromelain; CYS; cysteine; DNA; deoxyribonucleic acid; EDAC; ethyl-dimethylaminopropyl-carbodiimide; LMWH; low molecular weight heparin; MCS; mucolytic carrier system; MECS; mucolytic enzyme decorated carrier systems; NHS; N-h
Keywords: AHA; American Heart Association; CDT; catheter directed thrombolysis; CVI; chronic venous insufficiency; DOAC; direct oral anticoagulant; DVT; deep-vein thrombosis; FU; follow-up; ISTH; International Society on Thrombosis and Haemostasis; LMWH; low molecu
Keywords: AMAE; acute mesenteric arterial embolism; AMAT; acute mesenteric arterial thrombosis; CTA; computed tomography angiogram; ECG; electrocardiogram; LMWH; low molecular weight heparin; MDT; multidisciplinary meeting; SMA; superior mesenteric artery; TTE; tra
Keywords: ARTm; artefact movement; AOS; adhesive opaque surfaces; BMI; body mass index; CBF; cutaneous blood flow; DVT; deep vein thrombosis; IFU; indication for use; IPC; intermittent pneumatic compression; LMWH; low-molecular-weight heparin; LSCI; laser speckle c
Keywords: PE; pulmonary embolism; PROM; Patient Reported Outcome Measure; PESI; Pulmonary Embolism Severity Index; VTE; venous thromboembolism; VAS-score; visual analogue scale score; SF-36; short form health survey (36); DVT; deep venous thrombosis; LMWH; low-mole
Keywords: DVT; LMWH; Thromboprophylaxis; Pelvic Fracture; nonoperative;
Keywords: DVT; deep vein thrombosis; EMR; electronic medical record; LMWH; low molecular weight heparin; VTE; venous thromboembolism;
Keywords: APC; advanced pancreatic cancer; aPTT; activated partial thromboplastin time; CA 19-9; carbohydrate antigen 19-9; HR; hazard ratio; KPS; Karnofsky performance status; LMWH; low molecular weight heparin; OS; overall survival; PC; pancreatic cancer; QoL; qu
Keywords: ACT; activated clotting time; AF; atrial fibrillation; CHA2DS2-VASc; score for prediction of estimated risk of stroke in patients with non-valvular atrial fibrillation; EP; electrophysiologic; HAS-BLED; score that estimates risk of major bleeding for pati
Keywords: DVT; Deep vein thrombosis; PE; pulmonary embolism; IPC; intermittent pneumatic compression; UFH; unfractionated heparin; TIA; Transient Ischemic Attack; LMWH; low molecular-weight heparin; VP-scan; ventilation perfusion scan; HIT; heparin-induced thromboc
Keywords: BAL; bronchoalveolar lavage; BID; [bis in die] twice a day; CS; chondroitin sulphate; CXCL8; , C-X-C motif chemokine 8/interleukin-8; CXCR1/2; chemokine (C-X-C motif) receptor 1/2; EAU; experimental autoimmune uveitis; ELICO; ELISA-like competition assay;
Keywords: postpericardiotomy syndrome; risk factors; prognosis; tamponade; reintervention; AF; atrial fibrillation; BMI; body mass index; CABG; coronary artery bypass grafting; DECS; Dexamethasone for Cardiac Surgery trial; IL; interleukin; LMWH; low molecular weig
Keywords: Blood coagulation; Tissue factor; Thrombin; Platelets; Protease-activated receptors; Metastasis; AT; antithrombin; BMI; body mass index; CA-125; cancer antigen 125; CCC; clear cell carcinoma; CD; cluster of differentiation; CG; control group; DVT; deep ve
Keywords: ACR; American College of Rheumatology; COC; combined oral contraceptive; CQ; chloroquine; Cy; cyclophosphamide; HCQ; hydroxychloroquine; IV; intravenous; IVMP; intravenous methyl prednisone; LE; lupus erythematosus; LMWH; low-molecular-weight heparin; MMF
Keywords: CI; confidence interval; ESD; endoscopic submucosal dissection; HR; heparin replacement; LDA; low-dose aspirin; LMWH; low-molecular-weight heparin; NOAC; new oral anticoagulant; NOS; Newcastle-Ottawa Scale; RCT; randomized controlled trial; OR; odds ratio
Keywords: ACCP; American College of Chest Physicians; DOACS; Direct oral anticoagulants; HIT; heparin induced thrombocytopenia; LMWH; low molecular weight heparin; UFH; unfractionated heparin; VKA; vitamin K antagonists; Anticoagulation; Children; Pediatric; Hepari
Keywords: Glasgow Coma Scale; Loss of consciousness; Subdural hematoma; Traumatic brain injury; CT; Computed tomography; DASH; Delayed acute subdural hematoma; ED; Emergency department; GCS; Glasgow Coma Scale; INR; International normalized ratio; LMWH; Low-molecul
Keywords: APS; antiphospholipid syndrome; aPTT; activated partial thromboplastin time; BM; balloon maceration; CVC; central venous catheter; CVST; cerebral venous sinus thrombosis; DVST; Dural venous sinus thrombosis; ET; endovascular treatment; GC; guiding cathete
Keywords: Deep-vein thrombosis; Developing country; Neurosurgery; Postoperative; Pulmonary embolism; Venous thromboembolism; CT; Computed tomography; CTA; Computed tomographic angiography; Doppler USS; Doppler ultrasound scan with B-mode imaging; DVT; Deep-vein thr
Keywords: Venous thromboembolism; Deep venous thrombosis; Pulmonary emboli; Traumatic brain injury; Spinal injury; LMWH
Keywords: AF; atrial fibrillation; AUC; area under the curve; LMWH; low-molecular-weight heparin; mAVR; mechanical aortic valve replacement; OAT; oral anticoagulation therapy; OR; odds ratio; PTT; partial thromboplastin time; UFH; unfractionated heparin;
Keywords: urology; venous thrombosis; pulmonary embolism; cost-benefit analysis; prevention & control; ACCP; American College of Chest Physicians; ASCO; American Society of Clinical Oncology; DVT; deep vein thrombosis; EDP; extended duration prophylaxis; ICER; incr
Keywords: glycosaminoglycans; bioanalysis; processing; LC-MS; NMR spectroscopy; molecular weight determination; heparin; enoxaparin; bovine lung; porcine intestine; ATIII; antithrombin III; BLE; bovine lung heparin-derived enoxaparin; ESI; electrospray ionization
Keywords: NOAC; novel oral anticoagulant; VKA; vitamin K antagonist; AF; atrial fibrillation; VTE; venous thromboembolism; aPTT; activated partial thromboplastin time; LMWH; low-molecular weight heparin; Cmax; peak concentration; Tmax; time of peak concentration; A
Keywords: antibiotic therapy; deep venous thrombosis; pulmonary embolism; BRS; bleeding risk score; EMR; electronic medical record; ICD-9; International Classification of Disease, Ninth Revision; IMPROVE; International Medical Prevention Registry on Venous Thromboe
Keywords: AT; antithrombin; BSA; bovine serum albumin; CTA; cetyltrimethylammonium; Gal; galactose; GlcA; glucuronic acid; LMWH; low-molecular-weight heparin; NMR; nuclear magnetic resonance; SAX; strong anion exchange; USP; United States Pharmacopeia; Enoxaparin s
Keywords: HSC; hepatic stellate cells; PAR; protease activated receptor; LMWH; low molecular weight heparin; PVT; portal vein thrombosis; NO; nitric oxide; CCl4; carbon tetrachloride; MAP; mean arterial pressure; PP; portal pressure; PBF; portal blood flow; SMABF;
Keywords: factor V Leiden mutation; hypercoagulable state; hyperhomocysteinemia; livedoid vasculopathy; protein C deficiency; protein S deficiency; thrombophilia; thrombosis; ulcers; warfarin necrosis; AB; atrophie blanche; APC; activated protein C; APS; antiphosph
Keywords: myocardial infarction; pregnancy; prosthetic valves; valvular heart disease; AC; anticoagulation; BPHV; bioprosthetic heart valve; CHD; congenital heart disease; HF; heart failure; LMWH; low molecular weight heparin; MPHV; mechanical prosthetic heart val
Keywords: AIS; Abbreviated Injury Scale; DVT; deep vein thrombosis; EP; early prophylaxis; ICH; intracranial hemorrhage; IQR; interquartile range; LMWH; low-molecular-weight heparin; LP; late prophylaxis; OR; odds ratio; PE; pulmonary embolism; sTBI; severe traumat
Keywords: complication; dermatologic emergency; embolism; hypertension; hypotension; myocardial infarction; stroke; surgery; ABC; airway breathing and circulation; DBP; diastolic blood pressure; DVT; deep vein thrombosis; EMS; emergency medical services; LMWH; low
Keywords: UFH; unfractionated heparin; LMWH; low-molecular weight heparins; rFXa; recombinant factor Xa; HBC; heparin-binding copolymer; PEG; poly(ethylene glycol); PMAPTAC; poly(3-(methacryloylamino)propyl trimethylammonium chloride); MAPTAC; 3-(methacryloylami
Keywords: CF; cystic fibrosis; LTx; lung transplantation; CT; computed tomography; CVP; central venous pressure; ECMO; extracorporeal membrane oxygenation; LMWH; low-molecular-weight heparin; IVC; inferior venal cava; PICC; peripherally inserted central catheter; S
Keywords: SVT; superficial venous thrombosis; LMWH; low molecular weight heparin; EPL; essential phospholipids; LDF; laser-Doppler flowmetry; PO2; oxygen partial pressure; PCO2; carbon dioxide partial pressure; SCORAD; SCORing Atopic Dermatitis; IU; international u
Keywords: VTE; venous thromboembolism; LMWH; low molecular weight heparin; UFH; unfractioned heparin; VKA; vitamin k antagonists; RIETE; Registro Informatizado de Enfermedad TromboEmbólica; DVT; deep vein thrombosis; PE; pulmonary embolism; CUS; compressive ultras
Keywords: AUROC; area under the receiver operating curve; CABG; coronary artery bypass grafting; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; MCS; major cardiac surgery; NPV; negative predictiv
Keywords: AE; acute exacerbation; APACHE; Acute Physiology and Chronic Health Evaluation; BALF; BAL fluid; CRP; C-reactive protein; IPF; idiopathic pulmonary fibrosis; KL-6; Krebs von der Lungen-6; LDH; lactate dehydrogenase; LMWH; low-molecularweight heparin; NIV;